蛛网膜下腔出血与再入院:16001例住院患者全国再入院率、原因、危险因素与结局
基于2013年1月至9月全国再入院数据库,纳入12777例动脉瘤性蛛网膜下腔出血后存活出院患者,30天再入院962例(7.5%),90天再入院2153例(16.7%)。再入院常见原因为卒中、脑积水、败血症和头痛;大麻使用和糖尿病为30天及90天再入院的预测因素,高龄对30天再入院尤为易感。
要点
- aSAH后存活出院患者30天再入院率为7.5%(962/12777),90天再入院率为16.7%(2153/12777)。
- 再入院常见原因包括卒中、脑积水、败血症和头痛。
- 大麻使用和糖尿病是30天及90天再入院的预测因素,高龄对30天再入院尤为易感。
核心结论
- 蛛网膜下腔出血患者的许多再入院发生在30天随访期之外,且具有独特的危险因素,可能有助于识别高危患者。
研究设计与样本
- 查询2013年1月至9月全国再入院数据库,纳入所有年龄≥18岁、诊断为动脉瘤性蛛网膜下腔出血的患者,采集人口学、合并症、并发症和出院结局数据,采用单变量和多变量分析识别30天和90天再入院的原因及危险因素。
主要发现
- 12777例动脉瘤性蛛网膜下腔出血后存活出院患者中,962例(7.5%)在30天内再入院,2153例(16.7%)在90天内再入院。
- 再入院常见原因包括卒中、脑积水、败血症和头痛。
- 30天再入院患者中诊断脑积水者39.7%接受脑室腹腔分流术,90天再入院患者中该比例为51.2%。
- 多变量分析中,大麻使用和糖尿病是30天及90天再入院的预测因素,高龄对30天再入院尤为易感。
- 90天再入院的危险因素包括联邦医疗保险(Medicare)保险、甲状腺功能减退、初始出院至专业护理机构,以及包括肠梗阻、胃造瘘、急性肺损伤和脑水肿在内的若干索引并发症。
关键数值与推荐
- 30天再入院的平均费用为16.647美元、住院时长7.1天;90天再入院的平均费用为17,926美元、住院时长6.7天(原文费用数值写作「$16.647」,照录)。
- 30天内死亡率为2.8%,90天内死亡率为3.8%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The acute complications of aneurysmal subarachnoid hemorrhage (aSAH) often lead to readmissions, which are linked to hospital reimbursement. The national rates, causes, risk factors, and outcomes associated with 30-day and 90-day readmission after aSAH have not previously been reported. METHODS: The Nationwide Readmissions Database was queried from January to September 2013 for all patients (age ≥18 years) with a diagnosis of aSAH. Data points included demographics, comorbidities, complications, and discharge outcomes. Causes and risk factors for 30-day and 90-day readmission were identified in univariate and multivariable analysis. RESULTS: In 12,777 patients discharged alive after hospitalization for aSAH, 962 (7.5%) were readmitted within 30 days and 2153 (16.7%) within 90 days. Common causes of readmission included stroke, hydrocephalus, septicemia, and headache. At 30-day and 90-day readmission, 39.7% and 51.2% of patients with diagnosis of hydrocephalus underwent ventriculoperitoneal shunt placement, respectively. In multivariable analysis, cannabis use and diabetes were predictors of both 30-day and 90-day readmission and older patients were uniquely susceptible to 30-day readmissions. Risk factors for 90-day readmission included Medicare insurance, hypothyroidism, initial discharge to skilled nursing facility, and several index complications including bowel obstruction, gastrostomy, acute lung injury, and cerebral edema. Average cost and length of stay were calculated at 30-day ($16.647, 7.1 days) and 90-day readmission ($17,926, 6.7 days). Mortality was 2.8% within 30 days and 3.8% within 90 days. CONCLUSIONS: Many readmissions occur outside the 30-day follow-up period in patients subarachnoid hemorrhage and possess unique risk factors, which may help identify high-risk patients.
引用
- Rumalla K, Smith KA, Arnold PM, et al. Subarachnoid Hemorrhage and Readmissions: National Rates, Causes, Risk Factors, and Outcomes in 16,001 Hospitalized Patients. World Neurosurg. 2017. PMID: 29107164. doi:10.1016/j.wneu.2017.10.089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。